Spectral AI, Inc. is set to join the Russell Microcap® Index, focusing on medical diagnostics for faster and more accurate treatment decisions in wound care. The company's proprietary DeepView™ System is an AI-driven predictive medical device that assesses a wound's healing potential. Spectral AI's inclusion in the index marks a significant milestone in their evolution as a public company.
The DeepView™ System by Spectral AI has received UKCA Authorization for sales in the UK, with plans to generate commercial product revenue in the second half of 2024. The company has also been awarded a multi-year contract from the US Government for the development of the DeepView™ System. Spectral AI continues to advance clinical studies in the US to demonstrate the efficacy of their AI-driven system in providing healing assessments for burn wounds and diabetic foot ulcers.
Insider Monkey on MSN.com 12month
Insider Monkey on MSN.com 8month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.